Skip to main content
Equibles

Jennifer Cochran

Board Member

OmniAb, Inc. (OABI)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Jennifer Cochran

Jennifer Cochran is recorded as Board Member at OmniAb, Inc. (OABI). Earlier roles on record: Board Member at Ligand Pharmaceuticals Inc (LGND) until November 1, 2022. OmniAb, Inc. reported in an 8-K filed November 7, 2022 that Jennifer Cochran was appointed director, effective November 1, 2022. Ligand Pharmaceuticals Inc reported in an 8-K filed November 4, 2022 that Jennifer Cochran resigned as board of directors, effective November 1, 2022.

“Carolyn R. Bertozzi, Ph.D., Sarah Boyce, Jennifer Cochran, Ph.D., Matthew W. Foehr, John L. Higgins, Sunil Patel and Joshua Tamaroff were appointed as directors of OmniAb by APAC's shareholders to serve until the end of their respective terms and until their successors are elected and qualified, with John L. Higgins appointed to serve as Chairman of the Board.”
OmniAb, Inc. Form 8-K, filed November 7, 2022 · Read the filing
“On November 1, 2022, in connection with the Separation, Sarah Boyce, Jennifer Cochran and Sunil Patel each resigned from Ligand's board of directors.”
Ligand Pharmaceuticals Inc Form 8-K, filed November 4, 2022 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at OmniAb, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.